Autonomy News
@autonomynews.co
A worker-owned reproductive rights and justice publication cofounded by @garnethenderson.com and @susanrinkunas.com.
autonomynews.co
autonomynews.co
Pinned
Autonomy News
@autonomynews.co
· Jun 4
Welcome to Autonomy News
Welcome to Autonomy News, a new publication created and owned by two reproductive rights and justice journalists.
We write about bodily autonomy and the attacks levied by politicians and activists wh...
www.autonomynews.co
Hello world! We are Autonomy News, a new worker-owned reproductive justice news outlet cofounded by @garnethenderson.com and @susanrinkunas.com.
Our reporting will never be paywalled, and you can support our work with a subscription to keep it free for everyone.
Our reporting will never be paywalled, and you can support our work with a subscription to keep it free for everyone.
Reposted by Autonomy News
The Louisiana lawsuit is one of three active cases against the FDA that could result in judges restricting access to mifepristone nationwise. We're covering them all at the worker-owned @autonomynews.co:
Florida and Texas Sue the FDA, Planned Parenthood Loses Appeal, and More: December 15 News Roundup
Plus, Josh and Erin Hawley launch a new dark money group.
www.autonomynews.co
February 13, 2026 at 11:36 PM
The Louisiana lawsuit is one of three active cases against the FDA that could result in judges restricting access to mifepristone nationwise. We're covering them all at the worker-owned @autonomynews.co:
Reposted by Autonomy News
JUST IN: Republican Attorneys General of 21 states asked a judge to end telehealth prescriptions of abortion pills nationwide claiming FDA rules mean they can't enforce their restrictions/bans.
Hearing in Louisiana case against FDA is scheduled for 2/24
storage.courtlistener.com/recap/gov.us...
Hearing in Louisiana case against FDA is scheduled for 2/24
storage.courtlistener.com/recap/gov.us...
NEW: Louisiana and lawyer Erin Hawley of ADF just asked a federal judge to IMMEDIATELY end telemedicine prescriptions of the abortion drug mifepristone while their lawsuit against the FDA proceeds. They cite Fifth Circuit opinion and the Comstock Act of 1873
storage.courtlistener.com/recap/gov.us...
storage.courtlistener.com/recap/gov.us...
![screenshot 2/2 with some words highlighted in yellow. they are offset by asterisks below:
**Second, the 2023 REMS is “otherwise not in accordance with law.” 5 U.S.C. § 706(2)(A). Under 18 U.S.C. § 1462** [NOTE: THIS IS THE COMSTOCK ACT. IT'S 18 U.S.C 1461-1462], Congress prohibits the use of “any express company or other common carrier or interactive computer service” for “any drug, medicine, article, or thing designed, adapted, or intended for producing abortion.” Because a federal agency cannot permit what federal law expressly prohibits, FDA lacked authority to permanently remove the in-person dispensing requirement.
For these reasons, and as set forth fully in Plaintiffs’ Complaint and supporting Memorandum of Law, interim relief is necessary and appropriate to mitigate irreparable injuries caused by the 2023 REMS. Interim relief will serve the public interest and will not harm Defendants.
This Motion is made on the grounds specified in this Motion, the accompanying Memorandum of Law, the exhibits attached to this Motion, the Complaint, and the Complaint’s accompanying exhibits, as well as on such other and further oral or documentary evidence as may be presented to the Court at or before a hearing on this Motion.1 An exhibit list and a proposed order are attached.
docket here: https://www.courtlistener.com/docket/71544002/louisiana-v-u-s-food-drug-administration/?order_by=desc](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:4fdfjfnhhyeo4hsmoxpeazsg/bafkreifj2cvzqbotkuyfhsv5afpnhcuxtrjy4fgad6otbbnex4dis76yhe@jpeg)
February 13, 2026 at 11:24 PM
JUST IN: Republican Attorneys General of 21 states asked a judge to end telehealth prescriptions of abortion pills nationwide claiming FDA rules mean they can't enforce their restrictions/bans.
Hearing in Louisiana case against FDA is scheduled for 2/24
storage.courtlistener.com/recap/gov.us...
Hearing in Louisiana case against FDA is scheduled for 2/24
storage.courtlistener.com/recap/gov.us...
Reposted by Autonomy News
The maker of Nexplanon has about six months to inform AND recertify all of its prescribers. Glad a Bank of America analyst asked this on an earnings call, because the company didn't respond to @garnethenderson.com's multiple requests for comment
On an earnings call yesterday, the maker of birth control implant Nexplanon told investors it’s confident that newly heightened FDA regulations on its device won’t cause any bottlenecks.
But most providers I contacted for this story (and have heard from since) didn’t even know about the new rules.
But most providers I contacted for this story (and have heard from since) didn’t even know about the new rules.
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 13, 2026 at 5:38 PM
The maker of Nexplanon has about six months to inform AND recertify all of its prescribers. Glad a Bank of America analyst asked this on an earnings call, because the company didn't respond to @garnethenderson.com's multiple requests for comment
Reposted by Autonomy News
@autonomynews.co was the first non-trade publication to cover this story, and we broke the news to a lot of providers! Support our rigorous, independent journalism:
Support Autonomy News
We will never put our reporting or analysis behind a paywall. Your support makes that possible. Here are a few different ways to power our work:
Become a member
Support our journalism and help comb...
www.autonomynews.co
February 13, 2026 at 5:09 PM
@autonomynews.co was the first non-trade publication to cover this story, and we broke the news to a lot of providers! Support our rigorous, independent journalism:
Reposted by Autonomy News
Here’s the answer from Nexplanon maker Organon’s head of research and development in response to an investor question about the new FDA regulations, called a Risk Evaluation and Mitigation Strategy (REMS).
Full transcript is here: www.fool.com/earnings/cal...
Full transcript is here: www.fool.com/earnings/cal...
February 13, 2026 at 5:07 PM
Here’s the answer from Nexplanon maker Organon’s head of research and development in response to an investor question about the new FDA regulations, called a Risk Evaluation and Mitigation Strategy (REMS).
Full transcript is here: www.fool.com/earnings/cal...
Full transcript is here: www.fool.com/earnings/cal...
Reposted by Autonomy News
On an earnings call yesterday, the maker of birth control implant Nexplanon told investors it’s confident that newly heightened FDA regulations on its device won’t cause any bottlenecks.
But most providers I contacted for this story (and have heard from since) didn’t even know about the new rules.
But most providers I contacted for this story (and have heard from since) didn’t even know about the new rules.
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 13, 2026 at 5:01 PM
On an earnings call yesterday, the maker of birth control implant Nexplanon told investors it’s confident that newly heightened FDA regulations on its device won’t cause any bottlenecks.
But most providers I contacted for this story (and have heard from since) didn’t even know about the new rules.
But most providers I contacted for this story (and have heard from since) didn’t even know about the new rules.
Reposted by Autonomy News
Out of over 20,000 FDA-approved drugs, only 73 have active REMS—additional requirements that can make medication harder to get.
So it raised flags when the FDA put a REMS on Nexplanon, a birth control device available since 2011.
Read more from @garnethenderson.com at @autonomynews.co
So it raised flags when the FDA put a REMS on Nexplanon, a birth control device available since 2011.
Read more from @garnethenderson.com at @autonomynews.co
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 10, 2026 at 6:25 PM
Out of over 20,000 FDA-approved drugs, only 73 have active REMS—additional requirements that can make medication harder to get.
So it raised flags when the FDA put a REMS on Nexplanon, a birth control device available since 2011.
Read more from @garnethenderson.com at @autonomynews.co
So it raised flags when the FDA put a REMS on Nexplanon, a birth control device available since 2011.
Read more from @garnethenderson.com at @autonomynews.co
Read more:
The FDA recently approved the birth control implant Nexplanon for use up to five years, instead of three. But to providers' surprise, it also placed the device under a special monitoring protocol called REMS, which is infamous for the way it has limited access to medication abortion.
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 10, 2026 at 4:31 AM
Read more:
Reposted by Autonomy News
This may be the latest in the day we've ever gotten our @autonomynews.co roundup out, but in our defense, it's packed to the gills
An Onslaught of Lawsuits and State Legislation: February 9 News Roundup
Plus, what you missed on Autonomy News last week.
www.autonomynews.co
February 9, 2026 at 11:03 PM
This may be the latest in the day we've ever gotten our @autonomynews.co roundup out, but in our defense, it's packed to the gills
In case you missed our story on Friday: we're in the bad place
The FDA recently approved the birth control implant Nexplanon for use up to five years, instead of three. But to providers' surprise, it also placed the device under a special monitoring protocol called REMS, which is infamous for the way it has limited access to medication abortion.
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 9, 2026 at 4:10 PM
In case you missed our story on Friday: we're in the bad place
Good morning to all 10,000 of you, and thank you
![screenshot of our Bluesky profile showing we have 10,000 followers:
Autonomy News [verified check mark]
@autonomynews.co
10K followers 5 following 289 posts
A worker-owned reproductive rights and justice publication cofounded by @garnethenderson.com and @susanrinkunas.com.
autonomynews.co](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:jhlriymsjgbuqfkdm6tzir33/bafkreihj3z7tch6wbjr6eqqwmf6pybd4hbavmzcse2b4o25fwtwg2cevcq@jpeg)
February 9, 2026 at 4:03 PM
Good morning to all 10,000 of you, and thank you
Reposted by Autonomy News
Subscribe to @autonomynews.co, where we connect policy to people.
Support Autonomy News
We will never put our reporting or analysis behind a paywall. Your support makes that possible. Here are a few different ways to power our work:
Become a member
Support our journalism and help comb...
www.autonomynews.co
February 7, 2026 at 5:13 PM
Subscribe to @autonomynews.co, where we connect policy to people.
Reposted by Autonomy News
The biggest barriers to reproductive healthcare often sound inane and boring, which helps them fly under the radar. Behind this snooze of a regulatory change is a long history of paternalism at the FDA, including and perhaps especially under Democratic administrations, in fact:
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 7, 2026 at 5:11 PM
The biggest barriers to reproductive healthcare often sound inane and boring, which helps them fly under the radar. Behind this snooze of a regulatory change is a long history of paternalism at the FDA, including and perhaps especially under Democratic administrations, in fact:
Subscribe to our pro-abortion news outlet:
www.autonomynews.co/support/
www.autonomynews.co/support/
Embattled Planned Parenthood Affiliate CEO Wanted to Halt Abortions
Sources level new allegations against Planned Parenthood Southeast interim CEO Mairo Akposé, who remains in her role after an investigation they call a "farce."
www.autonomynews.co
February 6, 2026 at 7:51 PM
Subscribe to our pro-abortion news outlet:
www.autonomynews.co/support/
www.autonomynews.co/support/
That's right, we're pro-abortion
![screenshot from anti-abortion site LifeNews referring to us as pro-abortion, which they view as an insult and we take as a compliment:
"One pro-abortion [news outlet] specified some of the allegations from staff, which included that Akposé wanted Planned Parenthood to talk about abortion less, that she didn’t use staff’s “correct” pronouns, and that she wanted to make a statement when Charlie Kirk was assassinated."
in the bracketed text, they link to this story about the Planned Parenthood Southeast affiliate:
https://www.autonomynews.co/embattled-planned-parenthood-affiliate-ceo-wanted-to-halt-abortions/
technically this LifeNews post was written by a staffer of American Life League:
https://www.lifenews.com/2026/02/05/planned-parenthood-affiliate-gets-new-leader-to-push-its-abortion-agenda/](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:jhlriymsjgbuqfkdm6tzir33/bafkreigvxt7pvjsstw5jyenlugvyvfgkrs5bhv6c6ygoxut55m5oodkbwu@jpeg)
February 6, 2026 at 7:49 PM
That's right, we're pro-abortion
Reposted by Autonomy News
Autonomy News is doing reporting you're not getting anywhere else.
We will never put up a paywall but we need your support to power our work. Sign up for a paid subscription, drop us a one-time tip, grab merch, or make a tax-deductible donation here:
www.autonomynews.co/support/
We will never put up a paywall but we need your support to power our work. Sign up for a paid subscription, drop us a one-time tip, grab merch, or make a tax-deductible donation here:
www.autonomynews.co/support/
The FDA recently approved the birth control implant Nexplanon for use up to five years, instead of three. But to providers' surprise, it also placed the device under a special monitoring protocol called REMS, which is infamous for the way it has limited access to medication abortion.
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 6, 2026 at 6:11 PM
Autonomy News is doing reporting you're not getting anywhere else.
We will never put up a paywall but we need your support to power our work. Sign up for a paid subscription, drop us a one-time tip, grab merch, or make a tax-deductible donation here:
www.autonomynews.co/support/
We will never put up a paywall but we need your support to power our work. Sign up for a paid subscription, drop us a one-time tip, grab merch, or make a tax-deductible donation here:
www.autonomynews.co/support/
Reposted by Autonomy News
Don't sleep on this wonky-sounding story. An expert told Garnet this birth control news is "troubling" and asked “What else is this going to be applied to going forward? Is every reproductive health product going to be subject to this layer of scrutiny?"
NEW: Trump's FDA recently approved Nexplanon for five years of use, but it quietly added extra regulations that leave some providers worried about access. The agency imposed a REMS program that only exists for 73 other drugs—including medication abortion.
@garnethenderson.com in @autonomynews.co:
@garnethenderson.com in @autonomynews.co:
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 6, 2026 at 5:38 PM
Don't sleep on this wonky-sounding story. An expert told Garnet this birth control news is "troubling" and asked “What else is this going to be applied to going forward? Is every reproductive health product going to be subject to this layer of scrutiny?"
Reposted by Autonomy News
NEW: The FDA recently approved the contraceptive implant Nexplanon for use up to five years (instead of three). But it also placed the device under a REMS protocol, a special layer of regulation that could affect access.
Many providers did not yet know about the REMS when I contacted them.
Many providers did not yet know about the REMS when I contacted them.
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 6, 2026 at 4:43 PM
NEW: The FDA recently approved the contraceptive implant Nexplanon for use up to five years (instead of three). But it also placed the device under a REMS protocol, a special layer of regulation that could affect access.
Many providers did not yet know about the REMS when I contacted them.
Many providers did not yet know about the REMS when I contacted them.
If you think stories like this are important, support our independent, worker-owned news outlet:
Support Autonomy News
We will never put our reporting or analysis behind a paywall. Your support makes that possible. Here are a few different ways to power our work:
Become a member
Support our journalism and help comb...
www.autonomynews.co
February 6, 2026 at 5:19 PM
If you think stories like this are important, support our independent, worker-owned news outlet:
Experts expressed concern about the agency's lack of transparency.
February 6, 2026 at 5:19 PM
Experts expressed concern about the agency's lack of transparency.
The decision to require a REMS for Nexplanon was made after Trump took office. However, the FDA also decided to require a REMS for a new IUD under Biden. It's unclear whether the Nexplanon decision was political, or whether the agency has changed its approach to regulating certain contraceptives.
February 6, 2026 at 5:17 PM
The decision to require a REMS for Nexplanon was made after Trump took office. However, the FDA also decided to require a REMS for a new IUD under Biden. It's unclear whether the Nexplanon decision was political, or whether the agency has changed its approach to regulating certain contraceptives.
Nexplanon has been on the market since 2011. The FDA can require a post-approval REMS when it becomes aware of "new safety data," but the agency would not specify what new safety data its decision was based on. According to Organon, its clinical trial revealed no new safety information.
February 6, 2026 at 5:11 PM
Nexplanon has been on the market since 2011. The FDA can require a post-approval REMS when it becomes aware of "new safety data," but the agency would not specify what new safety data its decision was based on. According to Organon, its clinical trial revealed no new safety information.
Many providers had not yet heard about the Nexplanon REMS when contacted by Autonomy News. Nexplanon's maker, Organon, did not respond to multiple requests for comment.
February 6, 2026 at 5:11 PM
Many providers had not yet heard about the Nexplanon REMS when contacted by Autonomy News. Nexplanon's maker, Organon, did not respond to multiple requests for comment.
The FDA recently approved the birth control implant Nexplanon for use up to five years, instead of three. But to providers' surprise, it also placed the device under a special monitoring protocol called REMS, which is infamous for the way it has limited access to medication abortion.
The FDA Quietly Slapped More Restrictions on the Birth Control Implant
The agency recently approved Nexplanon for up to five years of use—but it also imposed extra regulations that leave some providers worried.
www.autonomynews.co
February 6, 2026 at 5:03 PM
The FDA recently approved the birth control implant Nexplanon for use up to five years, instead of three. But to providers' surprise, it also placed the device under a special monitoring protocol called REMS, which is infamous for the way it has limited access to medication abortion.